NO ATC N02CD01 · updated 2 Nov 2026
Erenumab shortage in Norway
Is there an Erenumab shortage in Norway?
Yes. As of 2 Nov 2026, 1 Erenumab product is reported short in Norway, the first since 20 Aug 2026. The company estimate for the return is 3 Dec 2026. Main reason: increased demand.
Also short in Spain, Ireland. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Aimovig 140 mg/ml injeksjonsvæske, oppløsning i ferdigfylt penn, 3 x 1 ml ferdigfylt penn | Novartis Europharm Limited (1) | 20 Aug 2026 | 3 Dec 2026 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).